PE Ratio:
135.47-5.60(-3.97%)Summary
- As of today, PTGX price to earnings ratio is 135.47, with a fall of -5.60 (-3.97%) during the most recent trading session on December 18, 2025.
- Over the past year, PTGX PE ratio has increased by +120.64 (+813.49%).
- PTGX PE ratio is now -10.02% below its all-time high of 150.56.
Performance
PTGX PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
PTGX PE Ratio Trends
| PeriodPeriod | PE RatioPE Ratio | PricePrice | TTM EPSTTM EPS | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | -4.0% | -4.0% | -11.1% | +0.0% |
| 1M1 Month | +0.8% | +0.8% | - | - |
| 3M3 Months | +55.2% | +37.9% | -11.1% | +0.0% |
| 6M6 Months | +91.1% | +59.1% | - | - |
| YTDYTD | +1375.7% | +122.3% | - | - |
| 1Y1 Year | +813.5% | +117.0% | -76.2% | -35.4% |
| 5Y5 Years | - | +306.2% | +129.3% | +714.2% |
PTGX PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 150.56 | -10.0% | 132.95 | +1.9% |
| 3M | 3-Month | 150.56 | -10.0% | 87.30 | +55.2% |
| 6M | 6-Month | 150.56 | -10.0% | 69.75 | +94.2% |
| 1Y | 1-Year | 150.56 | -10.0% | 8.34 | +1524.3% |
| 3Y | 3-Year | 150.56 | -10.0% | 8.34 | +1524.3% |
| 5Y | 5-Year | 150.56 | -10.0% | 8.34 | +1524.3% |
| All-Time | All-Time | 150.56 | -10.0% | 8.34 | +1524.3% |
PTGX PE Ratio History
| Date | Value |
|---|---|
| 2025 | 135.47(+1375.7%) |
| Date | Value |
|---|---|
| 2024 | 9.18 |
FAQ
- What is Protagonist Therapeutics, Inc. price to earnings ratio?
- What is the all-time high PE ratio for Protagonist Therapeutics, Inc.?
- What is PTGX price to earnings ratio year-to-date change?
- What is Protagonist Therapeutics, Inc. PE ratio year-on-year change?
What is Protagonist Therapeutics, Inc. price to earnings ratio?
The current PE ratio of PTGX is 135.47
What is the all-time high PE ratio for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high price to earnings ratio is 150.56
What is PTGX price to earnings ratio year-to-date change?
Protagonist Therapeutics, Inc. price to earnings ratio has changed by +126.29 (+1375.71%) since the beginning of the year
What is Protagonist Therapeutics, Inc. PE ratio year-on-year change?
Over the past year, PTGX price to earnings ratio has changed by +120.64 (+813.49%)